AI-generated summary
The authors reviewed randomised controlled trials of low level laser therapy applied to the joint capsule for chronic joint disorders. In 11 trials including 565 patients using the suggested dose range, they report that active treatment was associated with greater pain reduction on a visual analogue scale and more patients with improved global health status than placebo. The authors caution that heterogeneity in patients, procedures and trial design calls for careful interpretation.
- Participants
- 565
- Studies included
- 11
- Who or what was studied
- Patients with chronic joint disorders (knee, temporomandibular or zygapophyseal joints) included in 11 randomised controlled trials
- Limits stated in the abstract
- The authors note heterogeneity in patient samples, treatment procedures and trial design, and some included trials had low methodological quality scores (PEDro range 5 to 9).
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Systematic review, Dose, Visual analogue scale, Heterogeneity, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.